Trial Profile
Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Hydrocortisone (Primary) ; Pimecrolimus (Primary)
- Indications Prurigo nodularis
- Focus Therapeutic Use
- 24 Nov 2015 New source identified and integrated (NCT00507832).
- 24 Nov 2015 New trial record